SPP1 and liver disorder: Based on previous assessments of OPN’s translational potential as a biomarker and therapeutic target in liver disease, it is now recognized that unhealthy dietary patterns and alcohol consumption act synergistically to drive the onset and progression of MAFLD by inducing hepatic lipid metabolic dysregulation, oxidative stress, and inflammation [35,36].